REMATCH and beyond: The cost of treating heart failure using an implantable left ventricular assist device

Seminars in Cardiothoracic and Vascular Anesthesia

Volumn 10, Issue 3, 2006, Pages 253-255

  Dembitsky, Walter P ^a  

^a NONE   (United States)

Author keywords

Cost for congestive heart failure; Cost for left ventricular assist devices; REMATCH

Indexed keywords

CONFERENCE PAPER; CONGESTIVE HEART FAILURE; HEALTH CARE COST; HEART ASSIST DEVICE; HOSPITAL COST;

COSTS AND COST ANALYSIS; HEART FAILURE; HEART FAILURE, CONGESTIVE; HEART-ASSIST DEVICES; HUMANS;

EID: 33747148413     PISSN: 10892532     EISSN: None     Source Type: Journal    
DOI: 10.1177/1089253206291148     Document Type: Conference Paper

References (12)

1. Bleumink GS, Knetsch AM, Sturkenbloom MC, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. Eur Heart J. 2004;25:1614-1619.
2. Rose E, Gelijns AC, Moskowitz AJ, et al. Long term mechanical left ventricular assistance for end stage heart failure. N Engl J Med. 2001;345:1435-1443.
3. McMurray JJ, Stuart S. The burden of heart failure. Eur Heart J. 2003;4(Suppl D):D50-D58.
4. Roger UL. Trends in heart failure incidence and survival in a community based population. JAMA. 2004;292:344-350.
5. Lewis EF, Johnson PA, Johnson W, Collins C, Griffin L, Stevenson LW. Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant. 2001;20:1016-1024.
6. McMurray JJ. Epidemiology, aetiology, and prognosis of heart failure. Heart. 2000;83:569-602.
7. Heart Disease and Stroke Statistics 2005 Update. Dallas, TX: American Heart Association; 2005.
8. Lee WC, Chavez YE, Baker T, Luce BR. Economic burden of heart failure: a summary of recent literature. Heart Lung. 2004;33:362-371.
9. Oz MC, Gelijns AC, Miller L, et al. Left ventricular assist devices as permanent heart failure therapy: the price of progress. Ann Surg. 2003;238:577-583.
10. Park SJ. Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg. 2005;129:9-17.
11. Thoratec Destination Therapy Registry. Available at: http://www.thoratec. com/medical-professionals/clinical_trials.htm. Accessed June 26, 2006.
12. Long JW, Kfoury AG, Slaughter MS, et al. Long-term destination therapy with the Heartmate XVE left ventricular assist device: improved outcomes since the REMATCH study. Congest Heart Fail. 2005;11:133-138.